Neuroprotection of extremely immature newborns

Česká verzia

Authors: Z. Uhríková; M. Zibolen
Authors place of work: Neonatologická klinika, Jesseniova lekárska fakulta UK a Univerzitná nemocnica, Martin
Published in the journal: Čes-slov Neonat 2023; 29 (1): 52-55.
Category: Reviews

Summary

Research and subsequent clinical application of neuroprotective strategies are important priorities of modern neonatology. Consistent antenatal monitoring of the fetus, proper management of premature birth, support of the postpartum transition and optimal postnatal care are part of neuroprotective care for extremely immature newborns. The elimination of complications that trigger ischemia and inflammation are important from the point of view of minimizing brain maturation disorders, especially white matter. Neurological monitoring and early diagnosis of neurodevelopmental disorders of extremely immature newborns after discharge improve the long-term prognosis and subsequent quality of life.

Keywords:

neuroprotection – neonate – neuromonitoring

Zdroje

1. Stoll B, Hansen NI, Bell EF, Walsh MC, Carlo WA, Shankaran S, et al. Trends in care practices, morbidity, and mortality of extremely preterm neonates. JAMA 2015; 314: 1039–1051.

2. Galea CMS, Smithers-Sheedy H, Reid SM, Gibson C, Delacy M, et al. Cerebral palsy trends in Australia (1995–2009): a population-based observational study. Dev Med Child Neurol 2019; 61: 186–193.

3. Boyd SM, Tapawan SJ, Badawi N, Popat H. Protecting the brain of the micropreemie. Semin Fetal Neonatal Med 2022; 27(3): 101370.

4. Guillot M, Miller SP. The dimensions of white matter injury in preterm neonates. Semin Perinatol 2021; 45.

5. Wagenaar N, Chau V, Groenendaal F, Kersbergen KH, Poskitt KJ, Grunau RE, et al. Clinical risk factors for punctate white matter lesions on early magnetic resonance imaging in preterm newborns. J Pediatr 2017; 182: 34–40.

6. Ota E, Mori R, Middleton P, Tobe-Gai R, Mahomed K, Miyazaki C, et al. Zinc supplementation for improving pregnancy and infant outcome. Cochrane Database Syst Rev 2015; 2015(2): CD000230.

7. Medley N, Vogel JP, Care A, Alfirevic Z. Interventions during pregnancy to prevent preterm birth: an overview of Cochrane systematic reviews. Cochrane Database Syst Rev 2018; 11.

8. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972; 50(4): 515–525.

9. Xu H, Hu F, Sado Y, Ninomiya Y, Borza DB, Ungvari Z, et al. Maturational changes in laminin, fibronectin, collagen IV, and perlecan in germinal matrix, cortex, and white matter and effect of betamethasone. J Neurosci Res 2008; 86(7): 1482–1500.

10. De Silva DA, Synnes AR, von Dadelszen P, Lee T, Bone JN, Magee LA. Magnesium sulphate for fetal neuroprotection to prevent Cerebral Palsy (MAG-CP): implementation of a national guideline in Canada. Implement Sci 2018; 13(1): 1–16.

11. Victoria SC. Guidance: extreme prematurity. Secondary guidance: extreme prematurity 2021. Dostupný z: https://www.bettersafercare. vic.gov.au/clinical-guidance/neonatal/extreme-prematurity.

12. Jacobsson B, Simpson, JL. FIGO good practice recommendations for reducing preterm birth and improving child outcomes. Int J Gynecol Obstet 2021; 155: 1–4.

13. Kane S, Groom K, Crowther CA. How can obstetricians improve outcomes for infants born extremely preterm? Semin Perinatol 2021; 151477.

14. Bhatt S, Alison BJ, Wallace EM, Crossley KJ, Gill AW, Kluckow M, te Pas AB, Morley CJ, Polglase GR, Hooper SB. Delaying cord clamping until ventilation onset improves cardiovascular function at birth in preterm lambs. J Physiol 2013; 591: 2113–2126.

15. Oei J, Finer NN, Saugstad OD, Wright IM, Rabi Y, Tarnow-Mordi W, et al. Outcomes of oxygen saturation targeting during delivery room stabilisation of preterm infants. Arch Dis Child Fetal Neonatal Ed 2018; 103(5): F446–F454.

16. Wong SK, Chim M, Allen J, Butler A, Tyrrell J, Hurley T, McGovern M, Omer M, Lagan N, Meehan J, Cummins EP, Molloy EJ. Carbon dioxide levels in neonates: what are safe parameters? Pediatr Res 2022; 91(5): 1049–1056.

17. Lodha A, Entz R, Synnes A, Creighton D, YusufK, Lapointe A, et al. Early caffeine administration and neurodevelopmental outcomes in preterm infants. Pediatrics 2019: 143.

18. Rhee C, Sortica da Costa C, Austin T, Brady KM, Czosnyka M, Lee JK. Neonatal cerebrovascular autoregulation. Pediatr Res 2018; 84(5): 602–610.

19. Barrington K. Hypotension and shock in the preterm infant. Semin Fetal Neonatal Med 2008; 13: 16–23.

20. Curtis SF, Cotten MM, Laughon M, Clark RH, Greenberg RG. Indomethacin prophylaxis in preterm infants: changes over time. Pediatrics 2022; 149.

21. Christensen RD, Baer VL, Lambert, DK, Ilstrup SJ, Eggert, LD, Henry E. RBC transfusion and IVH. Transfusion 2014; 54: 104–108.

22. Coviello C, Keunen K, Kersbergen KJ, Groenendaal F, Leemans A, Peels B, et al. Effects of early nutrition and growth on brain volumes, white matter microstructure, and neurodevelopmental outcome in preterm newborns. Pediatr Res 2018; 83(1): 102–110.

23. Hyttel-Sorensen S, Pellicer A, Alderliesten T, et al. Cerebral near infrared spectroscopy oximetry in extremely preterm infants: phase II randomised clinical trial. Bmj 2015; 350: 763.

24. Hansen ML, Pellicer A, Gluud C et al. Detailed statistical analysis plan for the SafeBoosC III trial: a multinational randomised clinical trial assessing treatment guided by cerebral oxygenation monitoring versus treatment as usual in extremely preterm infants. Trials 2019; 20: 746.

25. Passera S, Boccazzi M, Bokobza C, et al. Therapeutic potential of stem cells for preterm infant brain damage: can we move from the heterogeneity of preclinical and clinical studies to established therapeutics? Biochem Pharmacol 2021; 186: 114461.

26. Ahn SY, Chang YS, Sung SI, Park WS. Mesenchymal stem cells for severe intraventricular hemorrhage in preterm infants: phase I dose-escalation clinical trial. Stem Cells Transl Med 2018; 7(12): 847–856.

27. Rangarajan V, Juul SE. Erythropoietin: emerging role of erythropoietin in neonatal neuroprotection. Pediatr Neurol 2014; 51(4): 481–488.